Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

AIM: Anticoagulation prophylaxis for stroke is recommended for at-risk patients with either persistent or paroxysmal atrial fibrillation (AF). We compared outcomes in patients with persistent vs. paroxysmal AF receiving oral anticoagulation. METHODS AND RESULTS: Patients randomized in the Rivaroxaba...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Heart J
Main Authors: Steinberg, Benjamin A., Hellkamp, Anne S., Lokhnygina, Yuliya, Patel, Manesh R., Breithardt, Günter, Hankey, Graeme J., Becker, Richard C., Singer, Daniel E., Halperin, Jonathan L., Hacke, Werner, Nessel, Christopher C., Berkowitz, Scott D., Mahaffey, Kenneth W., Fox, Keith A.A., Califf, Robert M., Piccini, Jonathan P.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4313363/
https://ncbi.nlm.nih.gov/pubmed/25209598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehu359
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados